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Abstract
Background: Hypophosphatasia (HP) is a rare inherited disorder characterized by a wide spectrum of defects
in mineralized tissues and caused by deficiency in the tissue non-specific alkaline phosphatase gene (ALPL). The
symptoms are highly variable in their clinical expression, and relate to numerous mutations in this gene. The first
clinical sign of the disease is often a premature loss of deciduous teeth, mostly in the moderate forms.
Aim: The purpose of this study was to document the oral features of HP patients and to relate theses features
to the six recognized forms of HP in 5 patients with known genotype and to investigate the genotype-phenotype
correlations.
Methods: Clinical and radiographic examinations were carried out. We collected medical and dental history in
the kindred and biochemical data. Finally, mutations in the ALPL gene were tested by DNA sequencing in SESEP
laboratory.
Results: We have for the first time related the known dental anomalies which occur as integral features of HP
to the recognized clinical forms of HP. We also pointed out striking dental abnormalities which were never
described in association with this rare disease. Accurate genotype-phenotype severity correlations were
observed.
Conclusion: This work allowed us to compare orodental manifestations in all the clinical forms of HP within the
patient's sample. According to the severity of the disorder, some dental defects were infrequent, while other
were always present. The long term prognosis of the permanent teeth varies from a patient to another. As
premature loss of primary teeth is often the first, and sometimes the only visible symptom of the milder forms,
the paediatric dentist plays a critical role in the detection and diagnosis of the disease.
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Hypophosphatasia (HP) is an inherited disorder charac-
terized by defective bone and tooth mineralization. HP is
due to mutations in the liver/bone/kidney alkaline phos-
phatase gene (ALPL, MIM 171760) encoding the tissue-
nonspecific alkaline phosphatase (TNAP) [1,2].
The disease is highly variable in its clinical expression, due
to strong allelic heterogeneity in the ALPL gene. More
than 190 mutations have been described and most of
them (79%) are missense mutations. This diversity results
in highly variable clinical expressivity and in a great
number of compound heterozygous genotypes [3].
Clinical expression ranges from the extremes of stillbirth
without mineralized bone to the isolated premature loss
of primary teeth [2,4]. Six clinical forms of HP are cur-
rently recognized depending upon the age of onset: lethal
perinatal (MIM 146300), prenatal (benign), infantile
(MIM 241500), childhood (MIM 241510), adult and
odontohypophosphatasia [5].
Severe forms of the disease (perinatal and infantile) are
transmitted as an autosomal recessive trait, whereas both
autosomal recessive and autosomal dominant transmis-
sion have been shown in moderate forms (childhood,
adult and odontohypophosphatasia) [6]. Moreover, one
case of de novo mutations was reported in 2005 [7].
The birth prevalence of severe HP has been estimated to
be 1/100000 [4]. The incidence of moderate forms has
never been estimated but is expected to be much higher
[5].
In addition to clinical and radiographical examinations,
laboratory assays are performed in case of suspicion of
HP: total serum alkaline phosphatatase activity is mark-
edly reduced. Molecular biology alone can establish the
diagnosis. The detection rate is about 95% in the severe
forms [5].
Currently, no established treatment exists for HP. Enzyme
replacement using a substitutive enzyme targeting miner-
alized tissue seems to be a promising way of treatment
which may become available in the next few years [8].
• In the lethal perinatal subtype, the patients show mark-
edly impaired mineralization in utero. Some infants sur-
vive a few days but have respiratory complications due to
hypoplastic lungs and rachitic deformities of the chest [5].
• In the prenatal benign form, despite prenatal symptoms,
there is a spontaneous improvement of skeletal defect [5].
• Infantile HP may appear normal at birth; however, the
clinical signs start during the first 6 months: hypercal-
cemia, rachitic deformities of the chest, premature cranio-
synostosis, widespread demineralization and rachitic
changes in the metaphyses are classical features. In infants
who survive (50%), there is often spontaneous improve-
ment in mineralization and remission of clinical prob-
lems. Short stature in adulthood and premature shed of
deciduous teeth are also common [1].
• The childhood form is heterogeneous. Clinical signs
appear after 6 months of age. Skeletal deformities, a delay
in walking, a short stature and a waddling are common
features. Signs of intracranial hypertension or failure to
thrive are typical. A history of fractures and bone pain usu-
ally exists as well. Premature loss of primary teeth is a trig-
ger sign predicting the diagnosis [2]. Spontaneous
remission of bone symptoms is well known, but the dis-
ease may re-appear in middle or late adulthood.
• The adult subtype develops during middle age. The first
complaint may be foot pain, related to stress fractures of
the metatarsals. Many of the patients present premature
loss of permanent teeth [6].
• Odontohypophosphatasia seems to represent a form of
the disease with only a dental phenotype. Indeed, this
form is characterized by spontaneous exfoliation of fully
rooted deciduous teeth, enlarged pulp chambers and root
canals, not associated with abnormalities of the skeleton.
Biochemical findings are generally indistinguishable from
those of patients presenting mild forms of HP [5,9,10].
Odontohypophosphatasia should be considered in any
patient with a history of early unexplained loss of teeth
[1].
Oral findings may represent the main clinical manifesta-
tions in the moderate subtypes (childhood, adult and
odontoHP), which are rarely diagnosed per se. Further-
more premature exfoliation of primary teeth is a "trigger
sign" which can lead to a possible diagnosis. The most fre-
quently reported oral symptoms are premature loss of
anterior primary teeth without root resorption, reduced
alveolar bone height. Hypoplasia of the cementum and
enlargement of the pulp chambers and root canals are
other findings [11]. Others features may exist, such as
enamel hypoplasia, delayed dentine formation or delayed
eruption [4,10,12-17].
The objectives of this study were to highlight dental
aspects of HP in all clinical forms, including abnormali-
ties of the permanent dentition and to relate the dental
anomalies to the various subtypes of HP. Genotype-phe-
notype correlations were done in order to orientate the
paediatrician and the paediatric dentist towards an earlierPage 2 of 10
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ment of the patient.
Methods
Five patients were referred for oral and dental 
examination
Oral and radiographical examinations
Examination and dental care were carried out within the
Paediatric Department of the Strasbourg Faculty of Den-
tistry and within the joint Reference Centre for Oral Man-
ifestations of Rare Diseases, for the patients 1, 2, 3 and 5.
Patient 4 was treated within the Paediatric Department of
the Faculty of Dentistry of Nancy.
Periondontal examination consisted of the assessment of
gingival inflammation, bleeding and probing depths. Esti-
mation of the dental anomalies included abnormalities of
number, size, shape and structure. We were also interested
in disorders of eruption, impactions, the age at which
teeth were lost and the exfoliation of posterior teeth.
On the radiographs (panoramic and peri-apical X-rays)
we focussed on the thickness of the alveolar bone, the size
of the pulp chambers and the degree of root resorption.
The orodental findings were documented using the Diag-
nosing Dental Defects Database record form D[4]. See
http://www.phenodent.org where a template of the form
can be downloaded.
Laboratory assays
The results of the biochemical investigations (serum AP
value) were collated at the time of the diagnosis.
Molecular biology
For all the patients, DNA sequencing of the ALPL gene was
performed in the SESEP laboratory in Versailles (France).
ALPL gene mutations database is available at: http://
www.sesep.uvsq.fr/Database.html.
Results
Patients
Patient 1
The proband was 36 years of age at first examination. He
is affected by the infantile form of HP. Despite the fact
that the patient presented signs of HP from birth, the diag-
nosis was only establish at 2 years of age, following the
loss of his anterior deciduous teeth. Molecular testing was
done at 31 years of age. At birth, the patient was diag-
nosed with craniosynostosis, multiple fractures and had
bone pain, which required several operative procedures.
All primary teeth were lost by the age of 8 years, but his
permanent dentition is still present at 36 years of age.
Patient 2
The boy was referred to the Paediatric Department of the
Hôpitaux Universitaires de Strasbourg at 9 years of age. He
has the infantile form of HP which was diagnosed at birth.
He had experienced multiple fractures and craniosynosto-
sis. Currently, he is confined to a wheelchair. Screening
for the HP mutations was performed to confirm the diag-
nosis. At 9 years of age, he has already lost all mandibular
primary teeth except the right lower first molar (84). The
maxillary primary central incisors and second primary
molars (51, 61, 55 and 65) had also been prematurely
exfoliated. Currently, the patient is in the mixed dentition
stage. The primary teeth still present are the maxillary lat-
eral incisors, the maxillary canines, the maxillary first
molars and the right lower first molar (52, 53, 54, 62, 63,
64 and 84), the permanent teeth present are the maxillary
left central incisor, all four lower incisors and all first
molars (21, 31, 32, 41, 42, 16, 26, 36 and 46).
Patient 3
A 10-months-old girl was referred by her paediatrician
because of the spontaneous and unexplained loss of her
primary lower central incisors (teeth 71 and 81), at 9
months of age. The patient's history reported normal
growth. Except the absence of the central lower mandibu-
lar incisors, the oral examination was entirely normal,
without inflammation of the gums. Thus, the child was
referred to the geneticist for diagnosis of suspected HP.
Medical findings showed a slight delay in growth. Radio-
graphs of the skeleton demonstrated general underminer-
alization of bones while biochemical investigations
revealed a low level of serum AP and an urinary excretion
of phosphoethanolamine, one of the substrates of the
enzyme. Molecular analysis revealed 2 mutations on the
ALPL gene and confirmed the diagnosis of a childhood
subtype of HP. Today, at 4.5 years of age, the patient has
lost all primary incisors, the lower primary canines and
the upper right canine (51, 52, 53, 61, 62, 71, 72, 73, 81,
82 and 83). The lower first primary molars (74 and 84) are
also very mobile. She also reports some difficulty in run-
ning and has bone pain.
Patient 4
The proband had her first visit at 1 year of age at the Pae-
diatric Department of the University of Nancy Faculty of
Dentistry. Her mother worried about the spontaneous
loss of the lower right primary central incisor tooth (81).
Although, the rest of the oral examination was normal, a
diagnosis of HP was considered. At first, the laboratory
assays did not show any abnormalities; the initial value of
serum AP was normal (224 UI/L), and the diagnosis of HP
was excluded. In the next two years, the patient lost 3
other primary teeth. The girl also complained of pain in
her lower limbs.Page 3 of 10
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low value of serum AP (67 UI/L); normal values range for
children from 123–283 UI/L. Molecular biology estab-
lished the diagnosis of a childhood form of HP after-
wards. At 4 years of age, she had already lost all her lower
primary incisors (71, 72, 81 and 82).
Patient 5
A 30-months-old boy was referred by a paediatric dentist
because of the premature loss of primary teeth. Except for
eczema, the child presented with normal development. At
19 months of age, this child had spontaneously lost his
four lower primary incisors (71, 72, 81 and 82) and the
upper left primary incisors and canine (61, 62 and 63) fol-
lowing trauma. The oral examination did not reveal any
gingivitis or bleeding. The patient was referred to the
Department of Medical Genetics with suspected HP.
Despite a normal growth pattern, radiographs of the skel-
eton revealed a distorted bone trabeculation with areas of
decreased radiolucency and slightly deficient bone under-
mineralization. Biochemical data revealed a low level
serum AP.
Molecular biology investigations showed one mutation
on ALPL gene and confirmed the diagnosis of childhood
HP. Today, at 6 years of age, the boy has lost all his man-
dibular and maxillary primary incisors and canines.
Oral features of HP
The results for the dental features are summarized in Table
1.
All the patients had premature loss of their primary teeth,
without gingival inflammation (Figure. 1, 2). The patients
affected more severely (Patients 1, 2 and 3), lost teeth
prior to one year of age and also exfoliated posterior teeth,
while the patients midly affected (Patients 4 and 5) lost
only their anterior teeth. Parents reported that before the
loss of teeth, they had noticed that the teeth elongate,
(like a continuing eruption). The history of premature
exfoliation of teeth was only reported in the kindred of
patient 2; his father losing his permanent teeth in his sec-
ond decade, without signs of periodontitis. Unfortu-
nately, most of the parents did not remember the age at
which they lost their own primary dentitions.
During clinical examination we did not notice any bleed-
ing, swelling or gingival recession; nor was there any per-
iodontal pocketing. In all cases, the teeth were lost with
intact and non-resorbed roots (Figure. 3).
Dental abnormalities
• Number: there were no missing or supernumerary teeth.
• Shape: abnormalities of the crown form of teeth were
observed for the two infantile forms of HP. The crowns
appeared small and bulbous, covered by thin enamel that
did not appear to reach the cervical area. Cervical constric-
tion was also present (Figure. 4, 5). Abnormalities of the
shape of the roots and coronal pulp are a common fea-
tures in all forms of HP. Primary teeth in all the patients
presented enlarged pulp chambers and root canals with
thin dentinal walls, visible both in anterior and posterior
teeth (Figure. 4, 5, 6). This was considered to be true
enlargement of the pulp chamber and not taurodontism
as there was no apical displacement of the furcation in the
molars, (the exception being in the case of patient 1 in
Table 1: Dental phenotypes of 5 cases of HP
Dental features 1 infantile
born in 1971
2 infantile
born in 1998
3 childhood
born in 2003
4 childhood
born in 2004
5 childhoodHP
born in 2002
Age at diagnosis 2 y 6 m 10 m 2,5 y 2,5 y
Age at examination 36 y 9 y 1 y 1 y 2,5 y
Loss of teeth < 1 year of age + + + - -
Loss of posterior teeth + + mobility - -
Inflammation of the gingiva Anomalies - - - - -
number - - - - -
shape: crowns + + - - -
shape: roots and pulp chambers + + + + +
size - - - - -
structure + + - - -
Impaction - + + - -
Delay in eruption + + + - -
Atrophy of alveolar bone + + + + +
Type of dental phenotype severe severe severe moderate moderate
Dental phenotype: a severe phenotype is associated with premature loss of teeth before 1 year of age and at least 3 types of dental anomalies. 
Moderate phenotype is associated with premature loss of teeth after 1 year of age and less than 3 types of dental anomalies.
Symbols: +: present, -: absent, m: months, y: yearPage 4 of 10
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rodontism) (Figure. 5).
• Size: we did not observed microdontia or macrodontia.
• Structure: enamel hypoplasia was present in both
patients affected by the infantile form of HP. Moreover,
we noticed abnormalities of the colour of the permanent
teeth in both patients being dark-yellow as observed in
cases of dentin dysplasia (Figure. 7).
• Eruption: submerging impaction of both lower second
primary molars (75 and 85) associated with intra-coronal
pulp resorption was found in patient 3. Delay in eruption
seems to be an important feature in patients 2 and 3 who
presented this symptom.
• Horizontal alveolar bone loss of nearly half of the root
length was seen on radiographs in patients 3 and 5.
Thus, classic features of HP; premature loss of primary
teeth, reduced alveolar bone height and enlargement of
coronal and root pulp chambers were found in all our
patients. Moreover, in the severe forms of the disease, we
observed other dental abnormalities such as changes in
tooth shape, structure and eruption.
Patient 4: Clinical view at 2.5 years of ageFigure 1
Patient 4: Clinical view at 2.5 years of age. The lower 
incisors (71, 72 and 81) are lost spontaneously without gingi-
vitis.
Patient 3: Clinical view of the mandibular arch at 21 months of ageFigure 2
Patient 3: Clinical view of the mandibular arch at 21 
months of age. There is no inflammation of the gingivae. 
The lower central incisors (71 and 81) have exfoliated at 9 
months of age while the mandibular lateral incisors (72 and 
82) exfoliated at 14 months of age.
Patient 5: Clinical view of the exfoliated mandibular right cus-pid (tooth 83) at 4 years of agFigure 3
Patient 5: Clinical view of the exfoliated mandibular 
right cuspid (tooth 83) at 4 years of age. The root is 
intact.
Patient 2: Panoramic radiograph at 7.5 years of ageFigure 4
Patient 2: Panoramic radiograph at 7.5 years of age. 
The radiograph reveals enlarged pulp chambers and abnor-
malities of the shape of the crowns.Page 5 of 10
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in severity of the dental symptoms for the patient 1
between 12 and 36 years of age mainly though the appo-
sition of dentin and the reduction of pulp spaces (Figure.
5 and 8).
Genotype-phenotype correlations
We observed a good correlation of serum AP levels with
the severity of the disease: the more severe the phenotype,
the lower are the serum AP values (Table 2). This confirms
that serum AP is a good marker of the severity of the dis-
ease [2].
The mutations detected by sequencing are reported in
Table 2. In patients 1, 2 and 3, two heterozygous muta-
tions were found, one of them corresponding to a severe
mutation (c.1361 A>G and c.550C>T, respectively), the
other being a mild mutation (c.571G>A) [18]. In patients
4 and 5, only one heterozygous mutation was detected,
each of them was reported to have a severe effect [18].
These mutations were from paternal origin in each case.
The father of patient 4 was asymptomatic but showed a
low serum AP level (25 UI/L, normal range (35–90), sug-
gesting dominant inheritance). No AP values were availa-
ble for the father of patient 5.
Patients 1, 2 and 3 were affected by a severe dental pheno-
type while in contrast, patients 4 and 5 were much more
midly affected.
Thus, the severe dental phenotype is correlated with a
more severe general phenotype and the presence of 2
mutations on the ALPL gene.
Patient 1: Panoramic radiograph at 12 years of ageFigure 5
Patient 1: Panoramic radiograph at 12 years of age. 
The radiograph shows enlarged pulp chambers and abnor-
mality of the shape of crown form. The second molars 
present more severe taurodontism than the first molars.
Patient 5: Panoramic radiograph at 5 years of ageFigure 6
Patient 5: Panoramic radiograph at 5 years of age. 
The radiograph reveals enlarged pulp chambers and reduced 
thickness of both enamel and dentin.
Patient 2: Clinical view at 7.5 years of ageFigure 7
Patient 2: Clinical view at 7.5 years of age. The clinical 
examination reveals midcrown linear enamel hypoplasia of 
the maxillary canines (53 and 63) and delay in the eruption of 
the maxillary right central incisor (tooth 11) whereas the left 
maxillary permanent central incisor (tooth 21) had erupted 
at 6.5 years of age. The colour of the permanent teeth is dark 
yellow.
Patient 1: Panoramic radiograph at 36 years of ageFigure 8
Patient 1: Panoramic radiograph at 36 years of age. 
The examination shows obliteration of the pulp chambers 
and reduced level of alveolar bone. The patient has a com-
plete permanent dentition whereas he lost all this primary 
teeth prematurely.Page 6 of 10
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mutation is known to be severe, there is a moderately
decreased serum AP value and a moderate form of the dis-
ease. This is due to the normal allele that provides enough
AP activity to limit the dominant negative effect of the
mutation.
Discussion
For the first time, oral findings in five patients affected by
several forms of HP are described in the same study. Our
purpose was to highlight the differences between all the
clinical forms. The classic features previously described in
the literature were present in all the subtypes [10-13,19].
The time point of clinical manifestations is currently used
to name the subtype of the disease, like perinatal, infantile
(before 6 months) and childhood (after 6 months) forms.
Indeed in our patients' sample such a classification is sub-
ject to questioning. For example even so affected by a clin-
ically recognised severe infantile form, patient 1 was only
diagnosed at 2 years of age. Patient 3 diagnosed at 10
months of age could be considered as a milder form of
infantile with delay in diagnosis or as a childhood form.
These considerations clearly show that especially the dis-
tinction of infantile and childhood hypophosphatasia
forms is somewhat arbitrary and the phenotype is more a
continuum than a precise subtype, even though, in the lit-
erature, these subtypes are usually cited.
Severe forms demonstrated premature loss of anterior
teeth before one year of age and exfoliation of posterior
teeth also. In the moderate forms, only primary anterior
teeth exfoliated. Furthermore, others dental defects such
as abnormalities of tooth shape, structure or eruption
preferentially occured in the infantile form. We have
shown that anomalies of the shape of the crowns and den-
tin defects, could also be a "trigger feature" pointing to a
diagnosis of HP in the severe forms. In addition, we
reported bilateral impaction associated with intra-coronal
pulp resorption in HP a feature never described in HP
before. Nevertheless, the submerged impacted second pri-
mary molars can also be seen in the normal child popula-
tion where permanent second premolars are congenitally
absent.
We did not find any patient with inflammation of the gin-
giva or periodontitis. The presence of periodontitis in HP
is controversial in the literature: Baab et al., Plagmann et
al., and Watanabe et al. described an association between
HP and periodontitis [16,20,21], while Valenza et al.
found no signicative differences in subgingival microbiota
of healthy patients and patients suffering from HP [22].
Baab et al. and El-Labban et al. discussed the possibility
that the weakened periodontal ligament was considerably
more susceptible to bacterial invasion and could promote
periodontitis [20,23]. Attachment loss in HP may be the
result of a cemental or alveolar bone defects rather than
the outcome of inflammation induced by bacterial
growth. Longitudinal studies will be of interest to follow
changes of the microbiota over time [22].
The eruption of permanent teeth must be considered care-
fully. As in patient 1, some patients could have lost all
their primary teeth prematurely and later present in adult-
hood with a complete permanent dentition and few or no
dental defects [14]. This may be attributable to a progres-
sive general improvement of affected patients from
infancy to adulthood [6]. Lepe et al. described a case of
childhood HP without dental manifestations in adult-
hood [14]. This hypothesis could explain, in addition to
incomplete penetrance of the disease, the reason why
most of the parents have no detectable dental defects in
their permanent dentition. Some may however have a his-
tory of early loss of primary teeth and this should be inves-
tigated during the medical and familial history. A precise
dental status of the family would indeed be also very
instructive especially in the cases of compound heterozy-
gosity where parents are affected by one mutation. In
another cohort [9] especially these parents were also
Table 2: Genotype-phenotype correlations in HP patients.
1 infantile 2 infantile 3 childhood 4 childhoodHP 5 childhoodHP
Dental phenotype severe severe severe moderate moderate
AP values 12 35 44 67 88
Genotype c.571>A (p.E191K)
c.1361A>G (p.H454R)
c.571>A (p.E191K)
c.550C>T (p.R184W)
c.526G>A (p.A176T)
c.648+1G>A
c.1250A>G (p.N417S) c. 212G>A (p.R71H)
Type of mutations moderate
and severe
moderate
and severe
moderate
and severe
severe severe
Mode of inheritance AR AR AR AD AD
Serum Alkaline Phosphatase (AP) values are those found at the age of diagnosis, i.e. between 6 months and 9 years of age. The normal values for 
children range from 123–283 UI/L.
Symbols: AR: autosomal recessive, AD: autosomal dominant
Footnote: Nucleotide and amino acid numbering are according to the international recommendation: the first nucleotide corresponds to the A of 
the ATG initiation codon.
The first amino acid corresponds to the ATG initiation codon.Page 7 of 10
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group only the father of patient 2 had a history of early
loss of primary teeth.
Moreover, there is no previous case report in the literature
which describes patients with more defects in the perma-
nent than in the primary dentition. Another point to be
considered is that: at the time of the occurrence of the dis-
ease in the adult form, odontogenesis has already been
completed. Thus, premature loss of teeth alone should be
looked for in patients affected by the adult form without
the presence of other dental anomalies. Nevertheless, if
some dental anomalies are present, it could be possible
that the patient has actually a childhood subtype undiag-
nosed at the time.
Of interest, are the strong differences between the pano-
ramic views at 12 and 36 years of age for the patient 1. At
13 years old, the patient presented with enlargement of
the pulp chambers, a slight reduced alveolar bone height
and small bulbous crowns, covered by thin enamel that
does not seem to reach the cervical area. Twenty years
later, all the teeth are still present, the level of the alveolar
bone is almost the same the pulp chambers have second-
ary dentine apposition. Enamel hypoplasia and a reduc-
tion of the enamel thickness were noted in the initial
radiograph. A hypothesis of a delay in dentin formation
could explain these changes.
In some reported cases, the same defects were observed in
both dentitions [13,15,23] and in other cases the perma-
nent dentition appears healthy [14]. Thus, we can not
establish a prognosis for the permanent dentition in the
light of the changes in the primary one. This indicates,
that carefull monitoring is necessary. Suitable prophylac-
tic programs should be launched, aiming at preserving
general health and a healthy oral cavity avoiding any bac-
terial invasion which could trigger periodontal disease
[11].
Alkaline phosphatase (AP) participates in tooth forma-
tion and is seen in dental and peridental cells – amelob-
lasts, odontoblasts, cementoblasts and osteoclasts [24].
Moreover, the enzyme is also expressed very intensively in
"satellite" cells: osteoprogenitor, supra-ameloblastic, and
subodontoblastic cells. This enzyme plays a significant
role during two critical phases, initiation and completion
of dental biomineralization. AP is intensely expressed
during terminal differentiation of osteoblasts and in ini-
tial biomineralization and decreases when bone mineral-
ization has been achieved [24]. These findings and the
role of the enzyme during these two essential phases
could explain why different types of dental anomalies
could be present in HP patients. Van den Bos et al.,
observed that both acellular and cellular cementum for-
mation was affected. They also showed that mineraliza-
tion of dentin is less likely to be under the influence of the
inhibitory action of inorganic pyrophosphates (one of the
substrates of TNAP) than mineralization of cementum.
This may suggest that different regulatory mechanisms
operate for mineralization in these two tissues [25].
More than 190 mutations are currently described world-
wide in HP patients. This diversity of mutations results in
variable clinical expressions even among the severe or
moderate types [9]. This may explain the heterogeneity of
the phenotype and the overlap of the clinical subtypes: for
instance, infantile and childhood HP share some clinical
symptoms, and patients with adult HP often recall child-
hood rickets or premature exfoliation of primary teeth
[5,15,26]. Depending upon the impact of the mutation
on enzyme function, the clinical manifestations are highly
variable, which is reflected by the age of onset [27].
Here patients 1, 2 and 3 carry two heterozygous muta-
tions, one moderate (c.571G>A or c.526G>A), the other
one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18].
This is a common situation in non-lethal forms of HP, the
moderate allele allowing the production of AP activity
from which depends the severity of the disease. The most
midly affected patients of our series were found heterozy-
gotes for the missense mutation c.1250A>G and
c.212G>A. These mutations have a dominant negative
effect that could explain the mild expression of the disease
at the heterozygous state. Indeed, by site-directed muta-
genesis we found that cells transfected with the mutations
R71H and N417S, and co-transfected with the wild type
allele, exhibit 30.5% and 26.5% of wild type alkaline
phosphatase activity, respectively, [Fauvert et al. manu-
script in preparation].
We found in our series very good correlation between the
severity of the symptoms and the AP value at time of diag-
nosis. Variation in clinical expression is currently known
to correlate well with variable residual enzyme activity.
Generally, the more severe the disease, the lower the
serum AP activity level appropriate for age [2]. Neverthe-
less, AP activity varies greatly with age and sex [5]. Patient
4, at 1 year of age had a normal serum AP value which at
first excluded the diagnosis of HP, but when tested again
2 years later he had a decreased value. Thus, molecular
biology is crucial to establish the definitive diagnosis
when biochemical and clinical data are not clear enough
[5].
Screening for the mutations in the ALPL gene is also of
greater importance for prediction of recurrence risk in
future pregnancies, carrier detection and prenatal diagno-
sis. The molecular diagnosis of each patient increases the
knowledge of the level of severity of symptoms associatedPage 8 of 10
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vide a better prognosis.
According to Hartsfield, premature exfoliation of primary
teeth in children younger than 5 years of age should sug-
gest a genetic or a systemic disease in the absence of
trauma, especially, in children younger than 3 years of age
[26]. The differential diagnosis includes inherited
immune diseases (Papillon-Lefèvre syndrome, Chediak-
Higashi syndrome, neutropenias), inherited non-immune
diseases (Ehlers-Danlos syndrome, Coffin-Lowry syn-
drome, hypophosphatemic rickets and dentinal dysplasia
type I), sensory neuropathies neoplasias and early-onset
periodontitis [26]. In moderate HP, the premature and
spontaneous loss of primary teeth is in most the cases the
only symptom. There is no pain and no association with
others oral features as inflammation of the gums, ulcera-
tions or abscesses [13,21]. Thus, this symptom is a trigger
sign in the milder forms of HP pointing to or predicting
the diagnosis [16,26]. Premature and spontaneous loss of
teeth alone without any history of trauma, should lead to
further investigation. For any patient with this symptom,
the diagnosis of HP should be considered.
Conclusion
Milder forms of HP still pose problems for timely and
accurate diagnosis [28,29]. Here, we have for the first time
related the known dental anomalies which occur in HP to
the various subtypes of HP. The paediatric dentist plays a
crucial role in the early detection of HP, as he is, the most
likely, the first person to meet the patient [27]. Such was
the case for our mildly affected patients and shows the
importance of accurate dental assessment and analysis in
pointing towards a diagnosis. An early correct diagnosis,
besides defining the disease, enables the provision of
effective therapy, when such becomes available in the
future.
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